Artwork

内容由i3 Health and I3 Health提供。所有播客内容(包括剧集、图形和播客描述)均由 i3 Health and I3 Health 或其播客平台合作伙伴直接上传和提供。如果您认为有人在未经您许可的情况下使用您的受版权保护的作品,您可以按照此处概述的流程进行操作https://zh.player.fm/legal
Player FM -播客应用
使用Player FM应用程序离线!

Additional Advances in SCLC Radiotherapy With Henry Park, MD, MPH + Free CME/NCPD/CPE Podcast

52:30
 
分享
 

Manage episode 381659226 series 3456244
内容由i3 Health and I3 Health提供。所有播客内容(包括剧集、图形和播客描述)均由 i3 Health and I3 Health 或其播客平台合作伙伴直接上传和提供。如果您认为有人在未经您许可的情况下使用您的受版权保护的作品,您可以按照此处概述的流程进行操作https://zh.player.fm/legal
Recently, Dr. Henry Park, Chief of Thoracic Radiotherapy at Smilow Cancer Network of Yale School of Medicine, served as faculty for i3 Health’s CME/NCPD/CPE–approved activity, Optimizing Treatment Selection, Sequencing, and Tolerability in Small Cell Lung Cancer (SCLC). This month, numerous updates in the use of radiotherapy for SCLC were presented at the American Society for Therapeutic Radiology and Oncology (ASTRO) Annual Meeting. In this interview, Dr. Park outlines the most significant updates presented at ASTRO and how he plans to incorporate them into the treatment of patients with SCLC. At the end of the interview, stay tuned to hear Dr. Park's full presentation and claim credit at https://gate.sc/?url=https%3A%2F%2Fwww.i3health.com%2Fcourse-information%2Fvideo-viewpoint-strategy-session-optimizing-treatment-selection-sequencing-and-tolerability-in-small-cell-lung-cancer&token=7e964b-1-1698857353561
  continue reading

41集单集

Artwork
icon分享
 
Manage episode 381659226 series 3456244
内容由i3 Health and I3 Health提供。所有播客内容(包括剧集、图形和播客描述)均由 i3 Health and I3 Health 或其播客平台合作伙伴直接上传和提供。如果您认为有人在未经您许可的情况下使用您的受版权保护的作品,您可以按照此处概述的流程进行操作https://zh.player.fm/legal
Recently, Dr. Henry Park, Chief of Thoracic Radiotherapy at Smilow Cancer Network of Yale School of Medicine, served as faculty for i3 Health’s CME/NCPD/CPE–approved activity, Optimizing Treatment Selection, Sequencing, and Tolerability in Small Cell Lung Cancer (SCLC). This month, numerous updates in the use of radiotherapy for SCLC were presented at the American Society for Therapeutic Radiology and Oncology (ASTRO) Annual Meeting. In this interview, Dr. Park outlines the most significant updates presented at ASTRO and how he plans to incorporate them into the treatment of patients with SCLC. At the end of the interview, stay tuned to hear Dr. Park's full presentation and claim credit at https://gate.sc/?url=https%3A%2F%2Fwww.i3health.com%2Fcourse-information%2Fvideo-viewpoint-strategy-session-optimizing-treatment-selection-sequencing-and-tolerability-in-small-cell-lung-cancer&token=7e964b-1-1698857353561
  continue reading

41集单集

すべてのエピソード

×
 
Loading …

欢迎使用Player FM

Player FM正在网上搜索高质量的播客,以便您现在享受。它是最好的播客应用程序,适用于安卓、iPhone和网络。注册以跨设备同步订阅。

 

快速参考指南